Study Of Attitude Towards Treatment And Factors Affecting Compliance In Patients With Schizophrenia

Antipsychotic medications are crucial for treating schizophrenia, but non-compliance is a significant issue. Understanding patient attitudes and reasons for non-compliance is key to improving treatment adherence. Study findings show that 40.3% non-compliance rate; higher PANSS scores and poor insight linked to non-compliance. Negative attitudes (DAI-10 scores) correlated with higher non-compliance. ROMI scale indicated better compliance if patients felt treatment benefits, had positive family support, or a good clinician relationship. Educating patients and families about treatment options can improve compliance.